Cybersecurity Stocks at an Intriguing Entry Point
...
10May
Read more...
10May
Read more...
10May
Read more...
10May
EV startups Rivian, Lucid, Nikola attempt to shore up cash
R1T trucks on the assembly line at the Rivian electric vehicle plant in Normal on April 11, 2022. Brian Cassella | Tribune News Service | Getty ImagesOnce-hot electric vehicle startups — years ago fueled by low interest rates, free cash and Wall Street bullishness — are now scrambling to prove...
10May
YELP, SG, NVAX, AKAM and more
Check out the companies making headlines before the bell. Akamai Technologies — Shares of the cloud company fell more than 10% after issuing weak guidance for the second quarter. Akamai sees adjusted earnings ranging from $1.51 to $1.56 per share on revenue of $967 million to $986 million. Analysts...
10May
Novavax and Sanofi to commercialize Covid vaccine, develop combo shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands.Patrick Van Katwijk | Getty ImagesNovavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to...
10May
Fine art sales are down as collectors pull back
A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox.The key May art sales at major auction houses are expected to be down from last year, as...
10May
Markets reprice Bank of England rate cut bets
Bank of England Governor Andrew Bailey attends the central bank's Monetary Policy Report press conference at the Bank of England, in London, on May 9, 2024. The Bank of England on Thursday kept its main interest rate at a 16-year high, but hinted at a cut over the summer...
10May
Moderna says RSV vaccine FDA approval delayed to end of May
Nikos Pekiaridis | Lightrocket | Getty ImagesModerna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to "administrative constraints" at the agency.The FDA was expected to make a decision on the RSV shot...
10May
Economy emerges from a technical recession
Commuters in London.Jason Alden/Bloomberg via Getty ImagesThe U.K. economy has emerged from recession as gross domestic product rose 0.6% in the first quarter, official figures showed Friday, beating expectations.Economists polled by Reuters had forecast growth of 0.4% on the previous three months of the year.The U.K. entered a shallow recession in...